Novo Nordisk sues spas, clinics selling ‘custom-made’ Ozempic, WSJ reports

Ozempic maker Novo Nordisk has filed lawsuits in federal courts across the U.S., accusing several medical spas, weight-loss clinics and wellness clinics of false advertising, trademark infringement and unfair competition, alleging they illegally said they were selling custom-made versions of Ozempic and other company medicines, The Wall Street Journal’s Sara Ashley O’Brien reports. The company has asked the courts to prevent the spas and clinics from claiming their drugs contain the main ingredient in Ozempic and related drugs and to require them to disclose their products aren’t affiliated with Novo Nordisk’s and are unapproved drugs.